RPg Family Wealth Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$26.9K Sell
110
-232
-68% -$59.9K 0.01% 200
2020
Q3
$97K Hold
342
0.05% 136
2020
Q2
$91.5K Sell
342
-75
-18% -$22.5K 0.06% 136
2020
Q1
$132K Hold
417
0.1% 101
2019
Q4
$124K Hold
417
0.07% 112
2019
Q3
$97.1K Hold
417
0.06% 121
2019
Q2
$97.5K Sell
417
-400
-49% -$92.4K 0.06% 121
2019
Q1
$193K Buy
817
+15
+2% +$4.72K 0.11% 100
2018
Q4
$241K Buy
802
+300
+60% +$95.7K 0.23% 51
2018
Q3
$177K Sell
502
-397
-44% -$137K 0.13% 66
2018
Q2
$261K Buy
899
+610
+211% +$171K 0.2% 62
2018
Q1
$79.1K Buy
289
+197
+214% +$61.2K 0.06% 74
2017
Q4
$29.3K Hold
92
0.02% 170
2017
Q3
$28.8K Sell
92
-70
-43% -$20.7K 0.02% 186
2017
Q2
$44K Buy
+162
New +$42.8K 0.04% 171

Other funds holding BIIB

RPg Family Wealth Advisory's BIIB Position: Q4 2020 in Review

RPg Family Wealth Advisory reduced its Biogen (BIIB) stake by 68% in Q4 2020, selling an estimated $59.9K and leaving 110 shares worth $26.9K. The position accounts for 0.01% of the portfolio, ranked #200.

RPg Family Wealth Advisory first reported a position in BIIB in Q2 2017 and has held it in 15 quarters since. The position peaked at $261K in Q2 2018. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • RPg Family Wealth Advisory held 110 shares of Biogen worth $26.9K as of Q4 2020.
  • RPg Family Wealth Advisory sold 232 Biogen shares in Q4 2020, an estimated $59.9K.
  • Biogen made up 0.01% of RPg Family Wealth Advisory's portfolio in Q4 2020, its #200 holding.
  • RPg Family Wealth Advisory first reported a position in Biogen in Q2 2017 and has held it in 15 quarters since.
  • RPg Family Wealth Advisory's Biogen position peaked at $261K in Q2 2018.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on RPg Family Wealth Advisory's 13F filing for Q4 2020, filed 16 Feb 2021.